Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
113.00    -0.50 (-0.44%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £111.66m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Net Asset Value(s)

25 Nov 2025 11:35

RNS Number : 9258I
Golden Prospect Precious Metals Ltd
25 November 2025
 

Golden Prospect Precious Metals Limited

(the "Company")

 

Net Asset Value

Golden Prospect Precious Metals Limited (LSE: GPM) announces that as at the close of business on 24 November 2025 its unaudited net asset value ("NAV") per ordinary share ("Share") was as follows:

Date of announcement

25 November 2025

Date of NAV

24 November 2025

NAV per share - undiluted, bid basis

100.93 pence per share

NAV per share - fully diluted*, bid basis

93.81 pence per share

No of shares in issue

93,248,499

Subscription Exercise Price

48.00 pence per share

Next Subscription Date

1 December 2025

 

*Notes relating to the NAV dilution

The dilution is in relation to the effect of the Company's embedded annual Subscription Right. Shareholders should note that the dilution refers to the NAV per share dilution, not to the dilution of Shareholders' holdings in the Company. All Shareholders have the right to take up their subscription rights on 1 December in each year (the "Record Date") and those who do take them up in full don't have their percentage holding in the Company diluted. For those investors who don't take up their subscription rights, the Company endeavours to place in the market the shares that they were entitled to subscribe for, and then return the net sale proceeds to those investors as a way to deliver to them as much as possible of the value of their subscription rights, therefore reducing the dilution effect of not subscribing.

The Board is currently anticipating that the majority of the Company's Shareholders will exercise their Subscription Rights in full, given the Company's share price is trading significantly higher than the Subscription Exercise Price. As a full exercise will generate proceeds in excess of EUR 8 million at the current 1.15 GBP:EUR exchange rate, the Board is expecting to scale back all Shareholders pro rata to their Subscription Rights pursuant to the Proposals in the circular dated 4 November 2022. The scale back would be effected in order to limit the issuance to EUR 8 million, being the maximum level the Company would not be required to issue a prospectus, which the Board believes would be unduly expensive compared to the total new money raised.

To account for the probable scale back, the calculation for the fully diluted NAV per share has been amended to reduce the maximum number of shares the Company can issue by 22.29%, to 14,492,753. This amendment has reduced the dilutive effect of the issuance of new Ordinary Shares. Please note the scale back factor, the maximum shares that can be issued and the NAV dilution are only current estimates. Any further amendments to the dilution calculation will be communicated in subsequent NAV announcements.

 

About the annual Subscription Right

Shareholders have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on the Record Date, as outlined in the circular published on 4 November 2022. The exercise price is equal to the undiluted NAV per share on 30 November one year prior. The aim of the programme is to enable to Company to grow through share issuance and it is subject to shareholder review at the annual general meeting ("AGM") in 2027 and at every fifth subsequent AGM thereafter.

 

 

Enquiries

 

Manulife | CQS Investment Management

Craig Cleland

 

 

+44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Robert Peel (Corporate Finance)

Daniel Balabanoff / Pauline Tribe (Sales)

 

 

+44 (0) 20 7908 6000

+44 (0) 20 7720 0500

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

 

 

+44 (0) 203 5303 600

Tavistock

Jos Simson / Gareth Tredway / Ruairi Millar

 

+44 (0) 20 7920 3150

 

 

About Golden Prospect Precious Metals

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector.

For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVPPGCWGUPAGGA
Date   Source Headline
5th Nov 20251:39 pmRNSNet Asset Value(s)
5th Nov 202510:18 amRNS-RCitywire - Specialist Equities Award 2025
4th Nov 20252:02 pmRNSNet Asset Value(s)
3rd Nov 20254:30 pmRNSNet Asset Value(s)
31st Oct 202512:53 pmRNSNet Asset Value(s)
31st Oct 20257:00 amRNSShareholder Notification re Subscription Rights
30th Oct 20251:35 pmRNSNet Asset Value(s)
29th Oct 20251:38 pmRNSNet Asset Value(s)
28th Oct 202512:14 pmRNSNet Asset Value(s)
27th Oct 202512:07 pmRNSNet Asset Value(s)
24th Oct 202512:42 pmRNSNet Asset Value(s)
23rd Oct 20252:09 pmRNSNet Asset Value(s)
22nd Oct 20253:47 pmRNSMonthly Investor Report September 2025
22nd Oct 20252:01 pmRNSNet Asset Value(s)
21st Oct 202512:14 pmRNSNet Asset Value(s)
20th Oct 20251:03 pmRNSNet Asset Value(s)
17th Oct 202511:51 amRNSNet Asset Value(s)
16th Oct 20251:44 pmRNSNet Asset Value(s)
15th Oct 20251:26 pmRNSNet Asset Value(s)
14th Oct 202512:32 pmRNSNet Asset Value(s)
13th Oct 20251:54 pmRNSNet Asset Value(s)
10th Oct 20251:48 pmRNSNet Asset Value(s)
9th Oct 202512:49 pmRNSNet Asset Value(s)
8th Oct 20253:31 pmRNSNet Asset Value(s)
7th Oct 20252:43 pmRNSNet Asset Value(s)
6th Oct 20251:04 pmRNSNet Asset Value(s)
3rd Oct 20251:22 pmRNSNet Asset Value(s)
2nd Oct 20251:43 pmRNSNet Asset Value(s)
1st Oct 20253:52 pmRNSNet Asset Value(s)
30th Sep 20253:54 pmRNSNet Asset Value(s)
29th Sep 20253:06 pmRNSNet Asset Value(s)
26th Sep 20253:28 pmRNSNet Asset Value(s)
25th Sep 20254:07 pmRNSNet Asset Value(s)
24th Sep 20253:09 pmRNSMonthly Investor Report - August 2025
24th Sep 20253:02 pmRNSNet Asset Value(s)
23rd Sep 20252:45 pmRNSNet Asset Value(s)
23rd Sep 20257:00 amRNSDirector/PDMR Shareholding
22nd Sep 20252:24 pmRNSNet Asset Value(s)
19th Sep 20251:11 pmRNSNet Asset Value(s)
18th Sep 202512:46 pmRNSNet Asset Value(s)
17th Sep 20253:31 pmRNSNet Asset Value(s)
16th Sep 20251:42 pmRNSNet Asset Value(s)
15th Sep 20254:48 pmRNSNet Asset Value(s)
12th Sep 20254:47 pmRNSNet Asset Value(s)
12th Sep 20257:00 amRNSInterim Report and Financial Statements
11th Sep 20253:14 pmRNSNet Asset Value(s)
10th Sep 20251:55 pmRNSNet Asset Value(s)
9th Sep 20252:29 pmRNSNet Asset Value(s)
8th Sep 202512:20 pmRNSNet Asset Value(s)
5th Sep 20252:48 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.